Finance

Lists
Why is CTEV down 8.16%?
Dive Deeper
CTEV:NYSE
Claritev Corp
$22.95
-8.16%
(-2.04) 1D
$22.95
0.00% (0.00)
After hours
Closed: Nov 17, 4:00:04 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTEV...
Open
$24.92
High
$25.37
Low
$22.08
Mkt. cap
391.87M
Avg. vol.
265.65K
Volume
210.78K
52-wk high
$55.50
52-wk low
$11.50
EPS
-$17.00
Beta
1.05
Shares outstanding
17.08M
No. of employees
3K
Open
$24.92
High
$25.37
Low
$22.08
Mkt. cap
391.87M
Avg. vol.
265.65K
Volume
210.78K
52-wk high
$55.50
52-wk low
$11.50
EPS
-$17.00
Beta
1.05
Shares outstanding
17.08M
No. of employees
3K
News stories
From web sources and news partners
About Claritev Corp
CEO-
Employees3K
Founded1980
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 4 analysts giving stock ratings to CTEV in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CTEV in the last 3 months.
Highest
Current $22.95
$47.00 (+104.79%)
Average
$40.25 (+75.38%)
Lowest
$30.00 (+30.72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Glen Santangelo
Barclays
Buy
Reiterated
$40.00
+74.3%
11/11/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$44.00
+91.7%
11/09/2026
Richard Close
Canaccord Genuity
Buy
Maintained
$47.00
+104.8%
11/10/2026
Stan Berenshteyn
Wells Fargo
Hold
Maintained
$30.00
+30.7%
11/10/2026
Jessica Tassan
Piper Sandler
Buy
Reiterated
$73.00
+218.1%
08/18/2026
Daniel Grosslight
Citi
Buy
Maintained
$45.00
+96.1%
08/10/2026
Jason Cassorla
Guggenheim
Buy
Reiterated
$44.00
+91.7%
08/07/2026
Last report
Nov 9, 2026
Fiscal period
Q3 2026
-$2.65 / $1.71
-254.80%miss
Revenue / Est. (USD)
268.31M / 256.13M
+4.76%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
246.55M
244.68M
257.48M
268.31M
Cost of goods sold
70.09M
69.08M
67.67M
69.77M
Cost of revenue
70.09M
69.08M
67.67M
69.77M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40.64M
46.04M
46.14M
58.36M
Operating expense
152.37M
157.13M
156.84M
169.84M
Total operating expenses
222.46M
226.21M
224.51M
239.61M
Operating income
24.09M
18.47M
32.97M
28.70M
Other non operating income
-
-
-
-
EBT including unusual items
-106.92M
-92.72M
-76.65M
-80.03M
EBT excluding unusual items
-75.04M
-80.89M
-67.09M
-71.96M
Income tax expense
-26.35M
-19.16M
-17.42M
-18.24M
Effective tax rate
24.64%
20.67%
22.73%
22.79%
Other operating expenses
-
-
-
-
Net income
-80.57M
-73.56M
-59.23M
-61.78M
Net profit margin
-32.68%
-30.06%
-23.00%
-23.03%
Earnings per share
-3.19
-3.30
-2.94
-2.65
Interest and investment income
279.00K
182.00K
195.00K
248.00K
Interest expense
-99.41M
-99.54M
-100.25M
-100.90M
Net interest expenses
-99.13M
-99.36M
-100.06M
-100.66M
Depreciation and amortization charges
25.89M
25.18M
24.80M
25.57M
EBITDA
135.83M
129.56M
143.67M
140.17M
Gain or loss from assets sale
8.68M
-
57.00K
68.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps